Trial · NCT01445535
Adverse events400
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 400
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Alkaline phosphatase | Metabolism and nutrition disorders | Cohort 1 - 3.4 mg/kg | 1 | 3 | 1 |
| other | Alkaline phosphatase | Metabolism and nutrition disorders | Cohort 2 - 4.8 mg/kg | 0 | 3 | 0 |
| other | Alkaline phosphatase | Metabolism and nutrition disorders | Cohort 3 - 8.5 mg/kg | 0 | 3 | 0 |
| other | Alkaline phosphatase | Metabolism and nutrition disorders | Cohort 4 - 15 mg/kg | 2 | 6 | 3 |
| other | Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip) | Immune system disorders | Cohort 1 - 3.4 mg/kg | 1 | 3 | 2 |
| other | Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip) | Immune system disorders | Cohort 2 - 4.8 mg/kg | 2 | 3 | 2 |
| other | Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip) | Immune system disorders | Cohort 3 - 8.5 mg/kg | 2 | 3 | 2 |
| other | Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip) | Immune system disorders | Cohort 4 - 15 mg/kg | 0 | 6 | 0 |
| other | Anorexia | Gastrointestinal disorders | Cohort 1 - 3.4 mg/kg | 1 | 3 | 2 |
| other | Anorexia | Gastrointestinal disorders | Cohort 2 - 4.8 mg/kg | 2 | 3 | 2 |
| other | Anorexia | Gastrointestinal disorders | Cohort 3 - 8.5 mg/kg | 0 | 3 | 0 |
| other | Anorexia | Gastrointestinal disorders | Cohort 4 - 15 mg/kg | 1 | 6 | 1 |
| other | Bilirubin (hyperbilirubinemia) | Metabolism and nutrition disorders | Cohort 1 - 3.4 mg/kg | 1 | 3 | 1 |
| other | Bilirubin (hyperbilirubinemia) | Metabolism and nutrition disorders | Cohort 2 - 4.8 mg/kg | 0 | 3 | 0 |
| other | Bilirubin (hyperbilirubinemia) | Metabolism and nutrition disorders | Cohort 3 - 8.5 mg/kg | 0 | 3 | 0 |
| other | Bilirubin (hyperbilirubinemia) | Metabolism and nutrition disorders | Cohort 4 - 15 mg/kg | 0 | 6 | 0 |
| other | Calcium, serum-low (hypocalcemia) | Metabolism and nutrition disorders | Cohort 1 - 3.4 mg/kg | 1 | 3 | 1 |
| other | Calcium, serum-low (hypocalcemia) | Metabolism and nutrition disorders | Cohort 2 - 4.8 mg/kg | 0 | 3 | 0 |
| other | Calcium, serum-low (hypocalcemia) | Metabolism and nutrition disorders | Cohort 3 - 8.5 mg/kg | 1 | 3 | 1 |
| other | Calcium, serum-low (hypocalcemia) | Metabolism and nutrition disorders | Cohort 4 - 15 mg/kg | 1 | 6 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01445535/events